BE1000141A3 - Acides hydroximiques d'ethers et de thioethers substitues par du 7-oxabicycloheptane, leur preparation et leur utilisation. - Google Patents

Acides hydroximiques d'ethers et de thioethers substitues par du 7-oxabicycloheptane, leur preparation et leur utilisation. Download PDF

Info

Publication number
BE1000141A3
BE1000141A3 BE8700782A BE8700782A BE1000141A3 BE 1000141 A3 BE1000141 A3 BE 1000141A3 BE 8700782 A BE8700782 A BE 8700782A BE 8700782 A BE8700782 A BE 8700782A BE 1000141 A3 BE1000141 A3 BE 1000141A3
Authority
BE
Belgium
Prior art keywords
sep
compound
ester
column
acid
Prior art date
Application number
BE8700782A
Other languages
English (en)
French (fr)
Inventor
Ravi Kannadikovilakom Varma
Eric Michael Gordon
Ligaya Magbanua Simpkins
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of BE1000141A3 publication Critical patent/BE1000141A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE8700782A 1986-07-23 1987-07-14 Acides hydroximiques d'ethers et de thioethers substitues par du 7-oxabicycloheptane, leur preparation et leur utilisation. BE1000141A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (1)

Publication Number Publication Date
BE1000141A3 true BE1000141A3 (fr) 1988-05-03

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700782A BE1000141A3 (fr) 1986-07-23 1987-07-14 Acides hydroximiques d'ethers et de thioethers substitues par du 7-oxabicycloheptane, leur preparation et leur utilisation.

Country Status (29)

Country Link
US (1) US4673685A (fi)
JP (1) JP2557894B2 (fi)
KR (1) KR950010596B1 (fi)
AT (1) AT397094B (fi)
AU (1) AU599384B2 (fi)
BE (1) BE1000141A3 (fi)
CA (1) CA1292003C (fi)
CH (1) CH674010A5 (fi)
DD (1) DD263990A5 (fi)
DE (1) DE3724152A1 (fi)
DK (1) DK383587A (fi)
ES (1) ES2006784A6 (fi)
FI (1) FI873207A (fi)
FR (1) FR2601953B1 (fi)
GB (1) GB2192882B (fi)
GR (1) GR871147B (fi)
HU (1) HU198495B (fi)
IE (1) IE60487B1 (fi)
IL (1) IL82919A0 (fi)
IT (1) IT1222054B (fi)
LU (1) LU86949A1 (fi)
NL (1) NL8701742A (fi)
NO (1) NO168359C (fi)
NZ (1) NZ220677A (fi)
PH (1) PH23711A (fi)
PT (1) PT85381B (fi)
SE (1) SE8702936L (fi)
YU (1) YU46321B (fi)
ZA (1) ZA874255B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0183238A2 (en) * 1984-11-30 1986-06-04 E.R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxa prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0013607B1 (en) * 1979-01-05 1983-03-23 National Research Development Corporation Substituted bicyclo (2,2,1)heptanes and bicyclo (2,2,1) hept-2-enes and their pharmaceutical compositions
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
DE3280020D1 (en) * 1981-12-23 1989-12-21 Nat Res Dev Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0183238A2 (en) * 1984-11-30 1986-06-04 E.R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxa prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
NZ220677A (en) 1989-12-21
AT397094B (de) 1994-01-25
ES2006784A6 (es) 1989-05-16
YU138187A (en) 1988-12-31
KR880001660A (ko) 1988-04-25
HU198495B (en) 1989-10-30
GB2192882B (en) 1990-05-09
SE8702936D0 (sv) 1987-07-22
ATA174887A (de) 1993-06-15
DK383587D0 (da) 1987-07-22
KR950010596B1 (ko) 1995-09-20
IE871675L (en) 1988-01-23
FR2601953B1 (fr) 1990-11-16
JPS6335576A (ja) 1988-02-16
HUT47115A (en) 1989-01-30
GB8714621D0 (en) 1987-07-29
CA1292003C (en) 1991-11-12
US4673685A (en) 1987-06-16
SE8702936L (sv) 1988-04-07
FR2601953A1 (fr) 1988-01-29
IT8721328A0 (it) 1987-07-16
PT85381B (pt) 1990-04-30
AU7444887A (en) 1988-01-28
AU599384B2 (en) 1990-07-19
GR871147B (en) 1987-12-04
GB2192882A (en) 1988-01-27
ZA874255B (en) 1988-02-24
PH23711A (en) 1989-09-27
IE60487B1 (en) 1994-07-27
DE3724152A1 (de) 1988-02-04
NO873069L (no) 1988-01-25
JP2557894B2 (ja) 1996-11-27
DK383587A (da) 1988-01-24
NO873069D0 (no) 1987-07-22
YU46321B (sh) 1993-05-28
NO168359C (no) 1992-02-12
PT85381A (en) 1987-08-01
NL8701742A (nl) 1988-02-16
DD263990A5 (de) 1989-01-18
FI873207A (fi) 1988-01-24
IL82919A0 (en) 1987-12-20
IT1222054B (it) 1990-08-31
NO168359B (no) 1991-11-04
LU86949A1 (fr) 1988-02-02
CH674010A5 (fi) 1990-04-30
FI873207A0 (fi) 1987-07-21

Similar Documents

Publication Publication Date Title
US5100889A (en) 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
FR2539129A1 (fr) Analogues amines des prostaglandines 7-oxabicycloheptane-substitues utiles comme medicaments cardio-vasculaires
FR2572725A1 (fr) Ethers bicycloheptane-substitues a action therapeutique
FR2553774A1 (fr) Analogues interphenylene de prostaglandines a substitution 7-oxabicycloheptane, utiles notamment comme agents cardiovasculaires
FR2574794A1 (fr) Analogues de prostaglandines tetrahydrothienyl-substitues a action cardiovasculaire
BE1000141A3 (fr) Acides hydroximiques d'ethers et de thioethers substitues par du 7-oxabicycloheptane, leur preparation et leur utilisation.
FR2585703A1 (fr) 7-oxabicycloheptane amides-thioamides, analogues de prostaglandines, a action cardio-vasculaire
LU85149A1 (fr) Analogues d'amino-prostaglandines substitues par un groupe 7-oxabicycloheptane
US5153327A (en) 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
FR2554818A1 (fr) 7-oxabicycloheptane thio ethers a action therapeutique
CH658247A5 (fr) Analogues de la prostaglandine substitues au 7-oxabicycloheptane.
US4608386A (en) 7-oxabicycloheptane ethers useful in the treatment of thrombotic diseases
FR2611718A1 (fr) Analogues d'amino prostaglandines 7-oxabicycloheptane substitues, a action therapeutique
FR2558836A1 (fr) Analogues d'oxaprostaglandines a substituant 7-oxabicyloheptane, a action therapeutique
FR2584074A1 (fr) 5,6-epoxy-7-oxabicycloheptane ethers utiles dans le traitement des thromboses
FR2563522A1 (fr) Analogues de 7 oxabicycloheptane prostaglandines, a action anti-inflammatoire, analgesique et cardiovasculaire
FR2581997A1 (fr) Analogues de prostaglandines a substituant thiabicycloheptane, a proprietes therapeutiques
US4588743A (en) 7-oxabicycloheptane-substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease
CA1301179C (en) 7-oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as "dual inhibitors"
FR2598419A1 (fr) Analogues d'amido-carbamoyl prostaglandines 7-oxabicycloheptane substitues, a action therapeutique
FR2503161A1 (fr) Nouvelles fluoroprostacyclines, leur preparation et leur application pharmaceutique
FR2580650A1 (fr) Analogues de prostaglandines a substituant 7-oxabicycloheptane, a proprietes therapeutiques
EP0611755B1 (fr) Nouveaux composés (cyclohexyl) alcéniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CA1072540A (fr) Procede de preparation de nouveaux 2,2-dimethyl steroides
CH316155A (fr) Procédé de préparation d'un 5-prégnène-17a,21-diol-3,11,20-trione-3,20-dialcoylène-cétal

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19960731